Thrombophilia in ethnic Arabs in Kuwait

Annals of Hematology

Volumn 73, Issue 6, 1996, Pages 283-290

  Mohanty, D ^a   Das, K C ^a   Al Hussain, H ^b   Naglen, P ^b   Eklof, B ^b   Marouf, Rajaa ^a   Khamis, Amal ^a   Al Majdi, M ^a  

^a KEM HOSPITAL   (India)

^b KUWAIT UNIVERSITY   (Kuwait)

Author keywords

DVT; Fibrinolysis; Protein C deficiency; Protein S deficiency; Thrombophilia

Indexed keywords

ANTITHROMBIN III; CHROMOGENIC SUBSTRATE; PROTEIN C; RABBIT ANTISERUM;

ADULT; ANTITHROMBIN III DEFICIENCY; ARAB; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BLOOD CLOTTING DISORDER; BRAIN BLOOD VESSEL; CONSANGUINITY; DEEP VEIN THROMBOSIS; ETHNIC GROUP; FAMILY HISTORY; FEMALE; HUMAN; IMMUNOASSAY; KUWAIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHILIA; THROMBOPHLEBITIS;

ABO BLOOD-GROUP SYSTEM; ADULT; ANTITHROMBIN III DEFICIENCY; ARABS; BLOOD COAGULATION DISORDERS; FEMALE; FIBRINOLYSIS; HUMANS; KUWAIT; MALE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHLEBITIS;

EID: 0030467324     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050242     Document Type: Article

References (39)

1. Mannucci PM, Tripodi A (1988) Inherited factors in thrombosis. Blood Rev 2:27-35
2. Tabernero, MD, Tomas JF, Alberca I, Orfao A, Borrasca AL, Vicente V (1991) Am J Hematol 36:249-254
3. Prins MH, Hirsh J (1991) A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism. Arch Intern Med 151:1721-1731
4. Schulman S, Wiman B, Duration of anticoagulant Trial study Group (1996) The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Thromb Haemost 75:607-611
5. Odergard OR, Lie M, Abildgard V (1975) Heparin cofactor activity measured with an amidolytic method. Thromb Res 6:287-294
6. Freiberger P, Knos M, Gustavsson S, Aurell L, Claesson G (1977) Methods of determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis 7:138-145
7. Stormorken H, Lund M, Holmsen I (1983) Vessel wall activator (tPA) as evaluated by poststasis euglobulin lysis time (PELT) in recurrent deep venous thrombosis. In: Jesperson J, Kluft C, Koresgaard O (eds) Clincal aspects of fibrinolysis and thrombolysis. South Jutland University Press, Esbjerg pp 293-309
8. Kluft C, Brakman P, Veldhuyzen-Stolk EC (1976) Screening of fibrinolytic activity in plasma euglobulin fraction on the fibrin plate. In: Davidson JF, Samama MM, Desnoyers PC (eds) Progress in chemical fibrinolysis and thrombosis, vol II. Raven, New York, pp 57-65
9. Dacie JV, Lewis SM (1984) Practical haematology, 6th edn. Churchill Livingston, London, pp 208-223
10. Seligsohn U, Berger A, Abend M, et al (1984) Homozygous protein-C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 310:559-562
11. Marlar RA, Montgomery RR, Madden RM (1988) Homozygous protein C deficiency. In: Bertina RM (ed) Protein C and related proteins. Churchill Livingston, New York, p 182
12. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C (1981) Deficiency of protein C in congenital thrombotic disease. J Clin Invest 68:1370-1373
13. Comp PC, Nixon RR, Cooper MR, Esmon CT (1984) Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 74:2082-2088
14. Broekmans AW, Veltkamp JJ, Bertina RM (1983) Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families. N Engl J Med 309:340-344
15. Schwartz HP, Fisher M, Hopmeier P, Batard MA, Griffen JH (1984) Plasma protein S deficiency in familial thrombotic disease. Blood 64:1297-1300
16. Comp PC, Esmon CT (1984) Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 311:1525-1528
17. Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH (1988) The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 59:18-22
18. Broekmans AW, van der Linden JK, Jansen-Koeter Y, Bertina RM (1986) Prevalence of protein C (PC) and protein S (PS) deficiency in patients with thrombotic disease. Thromb Res [Suppl VI]:135 (Abstr)
19. Reitsma PH, Poort SR, Bernardi F, et al (1993) Protein C deficiency: a data base of mutations. Thromb Haemost 69:77-84
20. Felez J, Rodriguez-Pinto R, Olivier A, et al (1987) Multicentric Spanish study of biological causes of deep vein thrombosis. Thromb Haemost 58:72 (Abstr)
21. Malm J, Laurell M, Nilson IM, Dahlback B (1987) Protein S and the fibrinolytic system in patients with a history of thrombosis. Thromb Haemost 58:229 (Abstr)
22. Ben Tal O, Zivelin A, Seligsohn U (1989) The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in Israel. Thromb Haemost 61:50-54
23. Grossman B, Duncan A (1987) Prevalence of primary coagulation deficiencies in patients with deep vein thrombosis. Thromb Haemost 58:72 (Abstr)
24. Briet E, Engesser L, Brommer EJP, Boekmans AL, Vicente V (1991) Thrombophilia: its causes and a rough estimates of its prevalence. Thromb Haemostas 58:39 (Abst)
25. Girolami A, Simioni P, Lazzaro AR, Cardiano I (1989) Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. Thromb Haemost 61:144-147
26. Sie P, Boneu B, Bierme R, Wiesel ML, Grunebaum L, Caze Nave JP (1989) Arterial thrombosis and protein S deficiency. Thromb Haemost 62:1040
27. De Stefano V, Leono G, Micalizzi P, Teofili L, Falappa PG, Pollari G, Bizz B (1991) Arterial thrombosis as clinical manifestation of congenital protein C deficiency. Ann Hematol 62:180-183
28. Miletich JP, Broze GJ (1986) Plasma protein C antigen in the normal population: what is deficiency? Circulation 74:92 (Abstr)
29. Vague PH, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi C, Collen D (1986) Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects. Metabolism 2:250-253
30. Mehta J, Mehta P, Lawson D, Saldeen T (1987) Plasma tissue plasminogen activator inhibitor levels in coronary artery disease. Correlation with age and serum triglyceride concentrations. J Am Coll Cardiol 9:263-268
31. Kawasaki T, Kambayashi J, Sakon M (1995) Hyperlipidemia: a novel etiologic factor in deep vein thrombosis. Thomb Res 79:147-151
32. Samama M (1994) Heterogeneous mechanisms responsible for reduced fibrinolytic capacity in patients with a history of venous thrombosis. Fibrinolysis 8:87-95
33. Schulman S, Rhedin A-S, Lindmarker P, Carlsson A, Larfars G, et al (1995) A comparison of six weeks and six months of oral anticoagulant therapy after a first episode of venous thromboemholism. N Engl J Med 332:1661-1665
34. Ridker PM, Vaughan DE, Stumpfer MJ, Manson JE, Hennekens CH (1993) Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 341:1165-1168
35. Korninger C, Lechner K, Niessner H, Gossinger H, Kundi M (1984) Impaired fibrinolytic capacity predisposes for recurrence of venous thrombosis. Thromb Haemost 52:127-130
36. Jansson J-H, Olofsson B-O, Nilsson TK (1993) Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease: a 7-year follow-up. Circulation 88:2030-2034
37. Prins MH, Hirsh J (1991) A critical review of the relationship between impaired fibrinolysis and myocardial infarction. Am Heart J 122:545-551
38. Juhan-Vague I, Valadier J, Alessi MC, Aillaud MF, Ansaldi J, Philip-Joet C, Holvet P, Serradimigni A, Collen D (1987) Deficient tPA release and elevated PA Inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Hemost 57:67-72
39. Hamsten A, Wiman B, De Faire U, Blomback M (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. Engl J Med 313:1557-1563